{
    "phase": "Phase 1",
    "source": "University of Colorado, Denver",
    "id_info": {
        "nct_id": "NCT02114333",
        "org_study_id": "13-3192"
    },
    "keyword": ["Shingles vaccine", "Immune response", "Zoster vaccine"],
    "location": {
        "status": "Recruiting",
        "contact": {
            "email": "nancy.lang@ucdenver.edu",
            "phone": "303-724-2454",
            "last_name": "Nancy Lang, BSN"
        },
        "facility": {
            "name": "Pediatric Infectious Diseases and Clinical Trials, Universtiy of Colorado School of Medicine ",
            "address": {
                "zip": "80045 ",
                "city": "Aurora ",
                "state": "Colorado ",
                "country": "United States"
            }
        },
        "investigator": {
            "role": "Principal Investigator",
            "last_name": "Myron J Levin, M.D."
        }
    },
    "sponsors": {
        "collaborator": {
            "agency": "GlaxoSmithKline",
            "agency_class": "Industry"
        },
        "lead_sponsor": {
            "agency": "University of Colorado, Denver",
            "agency_class": "Other"
        }
    },
    "condition": ["Adult", "Shingles", "Herpes Zoster"],
    "enrollment": {
        "$": "160",
        "@type": "Anticipated"
    },
    "start_date": "May 2014",
    "study_type": "Interventional",
    "brief_title": "Comparison of a Live Herpes Zoster Vaccine and a Recombinant Vaccine in 50 - 59 and 70 - 85 Year Olds",
    "eligibility": {
        "gender": "Both",
        "criteria": {
            "textblock": "Inclusion Criteria:"
        },
        "maximum_age ": "85 Years",
        "minimum_age ": "50 Years",
        "healthy_volunteers": "Accepts Healthy Volunteers"
    },
    "intervention": [{
        "description": "0.65ml, subcutaneous",
        "arm_group_label": ["A - Live zoster vaccine", "C - Live zoster vaccine"],
        "intervention_name": "Zostavax",
        "intervention_type": "Biological"
    }, {
        "other_name": "Recombinant vaccine",
        "description": "0.5ml, intramuscular",
        "arm_group_label": ["B - recombinant zoster vaccine", "D - recombinant zoster vaccine"],
        "intervention_name": "HZ/su vaccine",
        "intervention_type": "Biological"
    }, {
        "other_name": "normal saline",
        "description": "0.65ml, subcutaneous",
        "arm_group_label": ["A - Live zoster vaccine", "C - Live zoster vaccine"],
        "intervention_name": "Placebo",
        "intervention_type": "Biological"
    }],
    "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Parallel Assignment, Masking: Single Blind(Subject), Primary Purpose: Basic Science ",
    "brief_summary": {
        "textblock": "This study will compare the two vaccines that have been developed to prevent and/or lessen..."
    },
    "other_outcome": {
        "measure": "Unsolicited adverse events ",
        "time_frame": "Within 30 days of each vaccination",
        "safety_issue": "Yes"
    },
    "is_section_801": "No",
    "number_of_arms": "4",
    "official_title": "A Comparison of the Immunogenicity and Descriptive Safety of a Live Attenuated Herpes Zoster Vaccine and the GSK Herpes Zoster Recombinant HZ / su Candidate Vaccine in 50 - 59 Year Old and 70 - 85 Year Old Vaccine Recipients ",
    "overall_status": "Recruiting",
    "oversight_info": {
        "has_dmc ": "No ",
        "authority": ["United States: Food and Drug Administration", "United States: Institutional Review Board"]
    },
    "completion_date": {
        "$": "December 2019",
        "@type": "Anticipated"
    },
    "overall_contact": {
        "email": "nancy.lang@ucdenver.edu",
        "phone": "303-724-2454",
        "last_name": "Nancy Lang, BSN"
    },
    "primary_outcome": {
        "measure": "Interferon gamma/ Interleukin 2 (IFNg/IL2) dual color fluorospot number",
        "time_frame": "Measured up to Day 730",
        "safety_issue": "No"
    },
    "required_header": {
        "url": "https://clinicaltrials.gov/show/NCT02114333",
        "link_text": "Link to the current ClinicalTrials.gov record.",
        "download_date": "ClinicalTrials.gov processed this data on December 07, 2015"
    },
    "condition_browse": {
        "mesh_term": "Herpes Zoster"
    },
    "is_fda_regulated": "Yes",
    "lastchanged_date": "June 8, 2015",
    "overall_official": {
        "role": "Principal Investigator",
        "last_name": "Myron J Levin, M.D.",
        "affiliation": "University of Colorado School of Medicine"
    },
    "responsible_party": {
        "responsible_party_type": "Sponsor"
    },
    "secondary_outcome": {
        "measure": "glycoprotein-based enzyme-linked immunosorbent assay (gpELISA)",
        "time_frame": "Measured up to Day 730",
        "safety_issue": "No"
    },
    "verification_date": "June 2015",
    "firstreceived_date": "April 11, 2014",
    "location_countries": {
        "country": "United States"
    },
    "has_expanded_access": "No",
    "primary_completion_date": {
        "$": "February 2016",
        "@type": "Anticipated"
    }
}
